Condition Resources
Risk Evaluation and Mitigation Strategies
- FDA Announces New REMS for Drugs to Treat Low Platelet Counts
- The Changing Landscape of REMS in Pain Management
- REMS Improvements Proposed for Version 5 of Prescription Drug User Fee Act
- Impact of Risk Evaluation and Mitigation Strategies in Oncology
- Assessing a REMS Strategy: Keep It Simple and Responsible
Clinical Trials
Latest News
Multimedia: Videos
Multimedia: Podcasts
Upcoming Events
Most Popular
- Ten REMS Throw Retirement Party
- Impact of Risk Evaluation and Mitigation Strategies in Oncology
- Assessing a REMS Strategy: Keep It Simple and Responsible
- FDA Announces New REMS for Drugs to Treat Low Platelet Counts
- The Changing Landscape of REMS in Pain Management
- REMS Improvements Proposed for Version 5 of Prescription Drug User Fee Act
- Examining the Role of REMS in Opioid Safety
- FDA Initiative Focuses on Safe Use of Acetaminophen
- FDA Approves REMS for Actiq and Fentora
- Concentration of Popular Flu Drug Lowered
